Professional Nursing Program, Faculty of Nursing, Universitas Padjadjaran, Bandung 45363, Indonesia.
Department of Critical Care and Emergency Nursing, Faculty of Nursing, Universitas Padjadjaran, Bandung 45363, Indonesia.
Medicina (Kaunas). 2022 Sep 21;58(10):1321. doi: 10.3390/medicina58101321.
Patients with heart failure are a high-risk group who may have a higher mortality rate if infected during the COVID-19 pandemic. The problem of a patient's non-adherence to cardiac rehabilitation programs is still a challenge, resulting in disappointing long-term benefits of cardiac rehabilitation. Telehealth, including telerehabilitation, has grown in popularity to improve access to quality healthcare. It is more valuable and safer compared to usual rehabilitation care, especially during the current COVID-19 pandemic, to cut down unnecessary hospital visits and reduce the risk of cluster infections. This study aims to identify the efficacy of relevant randomized control trials (RCTs) using telerehabilitation in managing heart failure. The model, delivery care, safety, and efficacy were assessed. : This study was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-analysis for Scoping Reviews (PRISMA-ScR). The authors included relevant records published in the last ten years from three databases: PubMed/MEDLINE, ProQuest, and EBSCO. Each included study was further assessed using Cochrane's Risk of Bias (Rob 2) tool. : The telerehabilitation models consisted of cellphones, instant messaging, or online videoconferencing software. Some also included tool sets to monitor patients' vital signs regularly or during exercise. Most patients adhered to and completed all provided programs. Cardiac telerehabilitation successfully improved patients' physical fitness, quality of life, and mental health. No major adverse outcomes or significant complications were associated with the program. Cardiac telerehabilitation has the potential to deliver rehabilitation for heart failure patients, evidenced by its feasibility, efficacy, and safety. As a future perspective, this delivery care type can be applied throughout transmissible disease outbreaks or even globally.
心力衰竭患者属于高危人群，如果在 COVID-19 大流行期间感染，死亡率可能更高。患者不遵守心脏康复计划的问题仍然是一个挑战，导致心脏康复的长期效果不尽如人意。远程医疗（包括远程康复）的普及，旨在改善获得高质量医疗保健的机会。与常规康复护理相比，它更有价值且更安全，尤其是在当前 COVID-19 大流行期间，可以减少不必要的医院就诊次数，并降低聚集性感染的风险。本研究旨在确定使用远程康复管理心力衰竭的相关随机对照试验（RCT）的疗效。评估了模型、交付护理、安全性和疗效。方法：本研究根据系统评价和荟萃分析的首选报告项目（PRISMA-ScR）进行。作者纳入了过去十年中三个数据库（PubMed/MEDLINE、ProQuest 和 EBSCO）中发表的相关记录。每个纳入的研究都使用 Cochrane 偏倚风险（Rob 2）工具进一步评估。结果：远程康复模型包括手机、即时消息或在线视频会议软件。有些还包括工具包，以定期或在运动期间监测患者的生命体征。大多数患者坚持并完成了所有提供的方案。心脏远程康复成功改善了患者的身体状况、生活质量和心理健康。该方案没有与重大不良结局或严重并发症相关。心脏远程康复具有为心力衰竭患者提供康复治疗的潜力，其可行性、疗效和安全性得到了证实。作为未来展望，这种交付护理类型可以应用于传染病爆发期间，甚至可以在全球范围内应用。
